COMPANY
RyboDyn
Raises and deals from press releases
- Raise Seed · $10M · announced Mar 24, 2026 Company release ↗
Source quote
- Mar 24, 2026 · Company release ↗
“RyboDyn, Inc., a biotechnology company decoding the dark proteome using an AI-powered novel sequencing and discovery platform, today announced the initial close of a $10M Seed financing from a syndicate of new and existing investors”
- Mar 24, 2026 · Company release ↗
- Raise Pre-seed · $4M · announced Jan 9, 2025 Company release ↗
Source quote
- Jan 9, 2025 · Company release ↗
“Dark genome biotech company RyboDyn closes pre-seed fundraise from leading global investors to advance cancer immunotherapy SAN DIEGO, Jan. 9, 2025 /PRNewswire/ -- RyboDyn, Inc., has announced the discovery of a new proteome and the successful closing of a $4 million”
- Jan 9, 2025 · Company release ↗
Timeline
Funding
NIH awards 1
- NIH award 1R43GM163236-01 FY2025: $306,700 awarded for that fiscal year; activity R43 (SBIR); PI DAMBACHER, COREY MICHAEL; recipient as written: RYBODYN, INC., SAN DIEGO, CA. A novel spatial biology platform for prot source ↗